Liquidia Corp (LQDA): Next-Year EPS Estimate 81.47%

As of 2026-09-25, Liquidia Corp (LQDA) has a next-year EPS growth estimate of 81.47%. Featured in 4 EPS revision reports, most recently on 2026-05-19.

↑
Latest revision: 81.46% → 81.47%
Revised on 2026-09-08 · estimate has held for 16 consecutive trading sessions

On 2026-09-08, analyst consensus for LQDA's next-year EPS growth shifted from 81.46% to 81.47% — a positive change of 0.01 percentage points. The revised estimate has been sustained across 16 subsequent trading sessions. Current-year growth is projected at 483.50%.

What's Driving This

LQDA has been rising primarily after analysts raised its next-year EPS growth estimate on July 23, 2026, from 71.77% to 76.85%, a 5.08 percentage-point increase. The estimate has continued to climb, reaching 81.47%, indicating momentum beyond the initial revision. No recent news headlines were available to identify a specific catalyst such as an earnings beat, guidance raise, or product launch, so the move appears mainly estimate-driven.

Generated 2026-09-26 from news as of 2026-09-25

Current Snapshot

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
EPS growth next year
81.47%
EPS growth this year
483.50%
EPS next quarter (est)
$0.88
Last price
$68.43

EPS Revision History

81.5%81.5%08-2609-0209-1009-1709-25
Next-year EPS growth estimate · latest 30 days · 28 observations
565.0%565.0%08-2609-0209-1009-1709-25
Combined EPS growth (this year + next year) · latest 30 days · 28 observations
DateEPS Next YEPS This YNext Q (est)Price
2026-09-2581.47%483.50%$0.88$68.43
2026-09-2481.47%483.50%$0.88$70.95
2026-09-2381.47%483.50%$0.88$67.49
2026-09-2281.47%483.50%$0.88$68.64
2026-09-2181.47%483.50%$0.88$66.43
2026-09-2081.47%483.50%$0.88$66.88
2026-09-1881.47%483.50%$0.88$66.88
2026-09-1781.47%483.50%$0.88$68.39
2026-09-1681.47%483.50%$0.88$68.45
2026-09-1581.47%483.50%$0.88$65.72
2026-09-1481.47%483.50%$0.88$65.31
2026-09-1381.47%483.50%$0.88$66.74
2026-09-1181.47%483.50%$0.88$66.74
2026-09-1081.47%483.50%$0.88$67.85
2026-09-0981.47%483.50%$0.88$69.12
2026-09-0881.47%483.50%$0.88$67.68
2026-09-0781.46%483.50%$0.88$68.66
2026-09-0681.46%483.50%$0.88$68.66
2026-09-0481.46%483.50%$0.88$68.66
2026-09-0381.46%483.50%$0.88$68.63
2026-09-0281.46%483.50%$0.88$69.68
2026-09-0181.46%483.50%$0.88$66.91
2026-08-3181.46%483.50%$0.88$68.17
2026-08-3081.46%483.50%$0.88$67.69
2026-08-2981.46%483.50%$0.88$67.69
2026-08-2881.46%483.50%$0.88$67.69
2026-08-2781.46%483.50%$0.88$69.94
2026-08-2681.46%483.50%$0.88$71.36
2026-08-2581.46%483.50%$0.88$70.49
2026-08-2481.46%483.50%$0.88$70.27

Reports Featuring LQDA

Screen Performance

Aggregate stats across all 2051 tickers our top-EPS-revision screen has flagged over the past 177 days.

Median return since detection
+0.0%
% of tickers in the green
50%
Median return on winners
+22.6%
Large revisions captured
1770

Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.

Also Tracked by Our Screen

Frequently Asked Questions

What is Liquidia Corp's next-year EPS growth estimate?▾

As of 2026-09-25, Liquidia Corp (LQDA) has a next-year EPS growth estimate of 81.47%, based on analyst consensus.

When was the latest EPS estimate revision for LQDA?▾

The most recent revision occurred on 2026-09-08, when analysts adjusted the next-year EPS growth estimate from 81.46% to 81.47%.

What sector and industry does Liquidia Corp belong to?▾

Liquidia Corp operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.

How often is this EPS estimate data updated?▾

EPS revision data is refreshed daily from analyst consensus estimates. LQDA appears on this page because it was flagged by our daily top-EPS-revision-performer screen.

EPS revision data sourced from analyst consensus estimates, refreshed daily. Liquidia Corp (LQDA) appears here because it was detected by our daily top-EPS-revision-performer screen.